The Importance of EMT in Breast Cancer in African American Women
The Importance of EMT in Breast Cancer in African American Women
批准号:
8035882
负责人:
Patricia E Berg
金额:
$16.87万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2013-03-31
关键词:
African AmericanAgeBiologicalBiological AssayBreast Cancer CellCancer cell lineCaucasiansCaucasoid RaceCell LineCellsClinical ResearchDataDiagnostic Neoplasm StagingDiseaseDrug resistanceE-CadherinEstrogen receptor negativeExhibitsFrequenciesGene ExpressionGenesGoalsImmunohistochemistryLaboratoriesMalignant Epithelial CellMammary NeoplasmsMeasurementMeasuresMesenchymalNeoplasm MetastasisOutcomePatientsPlayProcessRNARoleSamplingStagingTimeTissuesTumor TissueTumor stageTumor-DerivedVimentinWomanepithelial to mesenchymal transitioninhibitor/antagonistmalignant breast neoplasmmigrationmortalityoverexpressionpreventpublic health relevancesmall moleculetherapeutic targettransdifferentiationtumortumor progression
中文摘要
描述(由申请人提供):我们的实验室发现了一种基因BP 1,该基因在89%的非裔美国妇女(AAW)肿瘤中被激活,而白人妇女(CW)的肿瘤中为57%。高水平的BP 1表达与侵袭性和较大的肿瘤相关。AAW的肿瘤也是侵袭性的-更高级别,更大,更常见的雌激素受体(ER)阴性,更具增殖性-导致AAW的死亡率比CW乳腺癌高近50%。BP 1还可能参与称为上皮向间充质转化(EMT)的过程,其与恶性上皮细胞向间充质细胞的转分化有关。BP 1上调Twist基因,一种EMT诱导物。EMT在乳腺癌的进展、侵袭、转移和耐药性中起作用,使其成为潜在的治疗靶点。临床研究表明,EMT是许多肿瘤预后不良的预测指标。总之,这些数据表明,EMT在AAW肿瘤中可能比CW更常见:BP 1的表达可能激活Twist,导致EMT,并且独立地,其他基因可能诱导EMT,导致AAW中观察到的更具侵袭性的肿瘤。假设。我们假定:(a)AAW的乳腺肿瘤比CW的肿瘤更频繁地经历EMT,和(B)高水平的BP 1表达与EMT相关。具体目标。目标1:目的:探讨AAW和CW肿瘤中EMT的发生率。目标2.确定BP 1在EMT中的作用。APPROACH.将在来自AAW的50个肿瘤组织和来自CW的50个肿瘤组织中检查EMT标志物,其与乳腺癌的年龄和分期相匹配。免疫组织化学将用于确定EMT标志物的表达,包括E-钙粘蛋白、波形蛋白和Twist。数据将与所有患者的临床病理学数据相关。将在来自肿瘤亚组的RNA中测量相同的标志物,其中组织是可用的。为了发现BP 1参与EMT,还将评估上述组织和RNA样品的BP 1水平。将研究来自AAW和CW肿瘤的乳腺癌细胞系,以确定BP 1和EMT标志物的水平。选择的表达低或高水平BP 1的细胞系将分别用于(i)过表达BP 1或(ii)抑制BP 1,然后测量E-钙粘蛋白、波形蛋白和Twist水平。微阵列将用于鉴定与BP 1和EMT相关的基因表达的其他变化。其他试验将包括测量侵袭和迁移,以及观察pBP 1过表达或减少后的形态学变化。意义如果EMT在AAW肿瘤中比CW更普遍,则在过渡期间表达的基因将成为治疗的良好靶点,并有可能减少或预防转移。如果BP 1是EMT的调节剂(通过Twist),那么使用小分子抑制剂siBP 1或其他方法靶向BP 1将有很强的理由。
公共卫生相关性:如果EMT在AAW肿瘤中比CW更普遍,则在过渡期间表达的基因将成为治疗的良好靶点,并有可能减少或预防转移。如果BP 1是EMT的调节剂(通过Twist),那么使用小分子抑制剂siBP 1或其他方法靶向BP 1将有很强的理由。
英文摘要
DESCRIPTION (provided by applicant): Our laboratory has discovered a gene, BP1, that is activated in 89% of the tumors of African American women (AAW), compared with 57% of the tumors of Caucasian women (CW). High level BP1 expression is associated with aggressive and larger tumors. Tumors of AAW are also aggressive - higher grade, larger, more frequently estrogen receptor (ER) negative, and more proliferative - resulting in an almost 50% higher mortality rate of AAW than CW with breast cancer. BP1 may also be involved in a process called the epithelial to mesenchymal transition (EMT), which is associated with transdifferentiation of malignant epithelial cells to mesenchymal cells. BP1 up-regulates the Twist gene, an inducer of EMT. EMT plays a role in breast cancer progression, invasion, metastasis, and drug resistance, making it a potential therapeutic target. Clinical studies indicate that EMT is predictive of poor outcome in many tumors. Together, these data suggest that EMT may be more frequent in tumors of AAW than CW: expression of BP1 may activate Twist, causing EMT and, independently, other genes may induce EMT, resulting in the more aggressive tumors seen in AAW. HYPOTHESES. We hypothesize that: (a) the breast tumors of AAW undergo EMT more frequently than tumors of CW, and (b) high level BP1 expression is associated with EMT. SPECIFIC AIMS. Aim 1. To determine the frequency of EMT in the tumors of AAW and CW. Aim 2. To determine the involvement of BP1 in EMT. APPROACH. Markers of EMT will be examined in 50 tumor tissues from AAW and 50 tumor tissues from CW, matched for age and stage of breast cancer. Immunohistochemistry will be used to determine the expression of EMT markers, including E-cadherin, vimentin, and Twist. Data will be correlated with clinico- pathological data available for all patients. The same markers will be measured in RNA from a subset of the tumors for which tissue is available. To discover the involvement of BP1 in EMT, the tissues and RNA samples described above will also be assessed for BP1 levels. Breast cancer cell lines derived from the tumors of AAW and CW will be studied to determine the levels of BP1 and markers of EMT. Selected cell lines expressing either low or high levels of BP1 will be used to (i) overexpress BP1 or (ii) repress BP1, respectively, followed by measurement of E-cadherin, vimentin and Twist levels. Microarrays will be used to identify additional changes in gene expression associated with BP1 and EMT. Additional assays will include measurement of invasion and migration, and observation of morphological changes after overexpression or reduction of pBP1. SIGNIFICANCE. If EMT is more prevalent in tumors of AAW than CW, genes expressed during the transition would make good targets for therapy, with the possibility of reducing or preventing metastases. If BP1 is a regulator of EMT (through Twist), there would be a strong rationale for targeting BP1 using small molecule inhibitors, siBP1 or other approaches.
PUBLIC HEALTH RELEVANCE: If EMT is more prevalent in tumors of AAW than CW, genes expressed during the transition would make good targets for therapy, with the possibility of reducing or preventing metastases. If BP1 is a regulator of EMT (through Twist), there would be a strong rationale for targeting BP1 using small molecule inhibitors, siBP1 or other approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Importance of EMT in Breast Cancer in African American Women
-
批准号:7880339
-
项目类别:
-
资助金额:$21.24万
-
财政年份:2010
-
负责人:Patricia E Berg
-
依托单位:
A Novel HOX Gene Target in Breast Cancer
-
批准号:6466446
-
项目类别:
-
资助金额:$24.14万
-
财政年份:2002
-
负责人:Patricia E Berg
-
依托单位:
A Novel HOX Gene Target in Breast Cancer
-
批准号:6623512
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2002
-
负责人:Patricia E Berg
-
依托单位:
BP1, A HOMEOBOX GENE, IS OVER EXPRESSED IN BREAST CANCER
-
批准号:6498011
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2001
-
负责人:Patricia E Berg
-
依托单位:
BP1, A HOMEOBOX GENE, IS OVER EXPRESSED IN BREAST CANCER
-
批准号:6287632
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2001
-
负责人:Patricia E Berg
-
依托单位:
REPRESSION OF HBS IN SICKLE CELL ANEMIA
-
批准号:6127712
-
项目类别:
-
资助金额:$7.2万
-
财政年份:1999
-
负责人:Patricia E Berg
-
依托单位:
REPRESSION OF HBS IN SICKLE CELL ANEMIA
-
批准号:6082319
-
项目类别:
-
资助金额:$11.93万
-
财政年份:1997
-
负责人:Patricia E Berg
-
依托单位:
REPRESSION OF HBS IN SICKLE CELL ANEMIA
-
批准号:2854174
-
项目类别:
-
资助金额:$2.2万
-
财政年份:1997
-
负责人:Patricia E Berg
-
依托单位:
REPRESSION OF HBS IN SICKLE CELL ANEMIA
-
批准号:2469647
-
项目类别:
-
资助金额:$18.0万
-
财政年份:1997
-
负责人:Patricia E Berg
-
依托单位:
REPRESSION OF HBS IN SICKLE CELL ANEMIA
-
批准号:2906158
-
项目类别:
-
资助金额:$20.23万
-
财政年份:1997
-
负责人:Patricia E Berg
-
依托单位:
REPRESSION OF HBS IN SICKLE CELL ANEMIA
-
批准号:6337234
-
项目类别:
-
资助金额:$7.38万
-
财政年份:1997
-
负责人:Patricia E Berg
-
依托单位:
REPRESSION OF HBS IN SICKLE CELL ANEMIA
-
批准号:6177558
-
项目类别:
-
资助金额:$20.88万
-
财政年份:1997
-
负责人:Patricia E Berg
-
依托单位:
REPRESSION OF HBS IN SICKLE CELL ANEMIA
-
批准号:2749642
-
项目类别:
-
资助金额:$10.41万
-
财政年份:1997
-
负责人:Patricia E Berg
-
依托单位:
DIAGNOSTIC KIT TO CLASSIFY SCL EXPRESSION IN CANCER
-
批准号:2026968
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1996
-
负责人:Patricia E Berg
-
依托单位:
NOVEL TRANSCRIPTION FACTOR WITH THERAPEUTIC POTENTIAL
-
批准号:2233633
-
项目类别:
-
资助金额:$9.96万
-
财政年份:1995
-
负责人:Patricia E Berg
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: